Levels of platelet activating factor in gingival crevice fluid following periodontal surgical therapy

Journal of Periodontal Research

Volumn 41, Issue 6, 2006, Pages 513-518

  Keles, G C ^a   Cetinkaya, B O ^a   Isildak, I ^a   Koprulu, H ^a   Acikgoz, G ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Gingival crevice fluid; High performance liquid chromatography; Periodontal surgery; Platelet activating factor

Indexed keywords

THROMBOCYTE ACTIVATING FACTOR;

ADULT; ARTICLE; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIOLOGY; FEMALE; GINGIVITIS; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTICS; PERIODONTITIS; PLASTIC SURGERY; RANDOMIZED CONTROLLED TRIAL; WOUND HEALING;

ADULT; CHROMATOGRAPHY, LIQUID; EPIDEMIOLOGIC METHODS; FEMALE; GINGIVAL CREVICULAR FLUID; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; MALE; MIDDLE AGED; PERIODONTAL DISEASES; PERIODONTAL POCKET; PLATELET ACTIVATING FACTOR; SURGICAL FLAPS; WOUND HEALING;

EID: 33750492906     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2006.00898.x     Document Type: Article

References (40)

1. Karimbux NY, Ramamurthy NS, Golub LM, Nishimura I. The expression of collagen I and XII mRNAs in Porphyromonas gingivalis-induced periodontitis in rats: the effect of doxycycyline and chemically modified tetracycline. J Periodontol 1998;69:34-40.
2. Carranza FA, McClain P, Schallhorn R. Regenerative osseous surgery. In: Newman MG, Takei HT, Carranza FA, eds. Clinical Periodontology. Philadelphia: W.B. Saunders, 2002: 804-824.
3. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Madzarevic M, Kenney EB. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodont Res 2002;37:300-306.
4. Ivanovski S, Li H, Daley T, Bartold PM. An immunohistochemical study of matrix molecules associated with barrier membrane-mediated periodontal wound healing. J Periodont Res 2000;35:115-126.
5. Garret S. Periodontal regeneration around natural teeth. In: Newman MG, ed. Annals of Periodontology. Chicago: The American Academy of Periodontology, 1996: 621-666.
6. Noguchi K, Morita I, Murota S. The detection of platelet-activating factor in inflamed human gingival tissue. Arch Oral Biol 1989;34:37-41.
7. Venable ME, Zimmerman GA, McIntyre TM, Prescott SM. Platelet-activating factor: a phospholipid autacoid with diverse actions. J Lipid Res 1993;34:691-702.
8. Antonopoulou S, Tsoupras A, Baltas G, Kotsifaki H, Mantzavinos Z, Demopoulos CA. Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients. Med Inflamm 2003;12:221-227.
9. Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev 1987;39:97-145.
10. Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990;259:697-708.
11. Emingil G, Coker I, Atilla G, Huseyinov A. Levels of leukotriene B4 and platelet activating factor in gingival crevicular fluid in renal transplant patients receiving cyclosporine A. J Periodontol 2000;71:50-57.
12. Emingil G, Cinarcik S, Baylas H, Huseyinov A. Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases. J Periodontol 2001;72:1032-1037.
13. Zheng ZG, Wood DA, Sims SM, Dixon SJ. Platelet-activating factor stimulates resorption by rabbit osteoclasts in vitro. Am J Physiol 1993;264:74-81.
14. Bassi F, Marchisella C, Schierano G et al. Detection of platelet-activating factor in gingival tissue surrounding failed dental implants. J Periodontol 2001;72:57-64.
15. Antonopoulou S, Demopoulos CA, Argyropoulos D, Baltas G, Kotsifaki H, Diamanti-Kipioti A. Identification of a new endogenous platelet-activating factor-like molecule in gingival crevicular fluid. Biochem J 1998;330:791-794.
16. Rasch MS, Mealey BL, Prihoda TJ, Woodard DS, McManus LM. The effect of initial periodontal therapy on salivary platelet-activating factor levels in chronic adult periodontitis. J Periodontol 1995;66:613-623.
17. Talonpoika JT, Hamalainen MM. Collagen III aminoterminal propeptide in gingival crevicular fluid before and after periodontal treatment. Scand J Dent Res 1992;100:107-110.
18. Embery G, Waddington R. Gingival crevicular fluid: biomarkers of periodontal tissue activity. Adv Dent Res 1994;8:329-336.
19. Giannobile WV, Lynch SE, Denmark RG, Paquette DW, Fiorellini JP, Williams RC. Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. A pilot study in beagle dogs. J Clin Periodontol 1995;22:903-910.
20. Griffiths GS, Moulson AM, Petrie A, James IT. Evaluation of osteocalcin and pyridinium crosslinks of bone collagen as markers of bone turnover in gingival crevicular fluid during different stages of orthodontic treatment. J Clin Periodontol 1998;25:492-498.
21. Kuru L, Griffiths GS, Petrie A, Olsen I. Changes in transforming growth factor-beta1 in gingival crevicular fluid following periodontal surgery. J Clin Periodontol 2004;31:527-533.
22. Okuda K, Miyazaki A, Momose M et al. Levels of tissue inhibitor of metalloproteinases-1 and matrix metalloproteinases-1 and -8 in gingival crevicular fluid following treatment with enamel matrix derivative (EMDOGAIN). J Periodont Res 2001;36:309-316.
23. Holmlund A, Hanstrom L, Lerner UH. Bone resorbing activity and cytokine levels in gingival crevicular fluid before and after treatment of periodontal disease. J Clin Periodontol 2004;31:475-482.
24. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
25. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:533-551.
26. Servillo L, Iorio EL, Quagliuolo L, Camussi G, Balestrieri C, Giovane A. Simultaneous determination of lysophospholipids by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl 1997;689:281-286.
27. Park JS, Suh JJ, Choi SH et al. Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects. J Periodontol 2001;72:730-740.
28. Cortellini P, Carnevale G, Sanz M, Tonetti MS. Treatment of deep and shallow intrabony defects. A multicenter randomized controlled clinical trial. J Clin Periodontol 1998;25:981-987.
29. Aimetti M, Romano F, Pigella E, Pranzini F, Debernardi C. Treatment of wide, shallow, and predominantly 1-wall intrabony defects with a bioabsorbable membrane: a randomized controlled clinical trial. J Periodontol 2005;76:1354-1361.
30. Mayfield L, Soderholm G, Hallstrom H et al. Guided tissue regeneration for the treatment of intraosseous defects using a biabsorbable membrane. A controlled clinical study. J Clin Periodontol 1998;25:585-595.
31. Bremm LL, Sallum AW, Casati MZ, Nociti FH, Sallum EA. Guided tissue regeneration in Class II furcation defects using a resorbable polylactic acid barrier. Am J Dent 2004;17:443-446.
32. Tersin J. Studies of gingival conditions in relation to orthodontic treatment. I. The relationship between amounts of gingival exudate and gingival scores, plaque scores and gingival pocket depths in children undergoing orthodontic treatment. Swed Dent J 1973;66:165-175.
33. Griffiths GS, Sterne JA, Wilton JM, Eaton KA, Johnson NW. Associations between volume and flow rate of gingival crevicular fluid and clinical assessments of gingival inflammation in a population of British male adolescents. J Clin Periodontol 1992;19:464-470.
34. Coonts BA, Whitman SL, O'Donnell M et al. Biodegradation and biocompatibility of a guided tissue regeneration barrier membrane formed from a liquid polymer material. J Biomed Mater Res 1998;42:303-311.
35. McManus LM, Marze BT, Schiess AV. Deficiency of salivary PAF in edentulous individuals. J Periodont Res 1990;25:347-351.
36. Garito ML, Prihoda TJ, McManus LM. Salivary PAF levels correlate with the severity of periodontal inflammation. J Dent Res 1995;74:1048-1056.
37. Ribaldi E, Guerra M, Mezzasoma AM, Staffolani N, Goracci G, Gresele P. PAF levels in saliva are regulated by inflammatory cells. J Periodont Res 1998;33:237-241.
38. Offenbacher S, Collins JG, Arnold RR. New clinical diagnostic strategies based on pathogenesis of disease. J Periodont Res 1993;28:523-535.
39. Vardar S, Buduneli E, Turkoglu O et al. Therapeutic versus prophylactic plus therapeutic administration of omega-3 fatty acid on endotoxin-induced periodontitis in rats. J Periodontol 2004;75:1640-1644.
40. Vardar S, Buduneli E, Baylas H, Berdeli AH, Buduneli N, Atilla G. Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats. J Periodontol 2005;76:99-106.